These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 16618783)

  • 1. Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.
    Reddy BS; Wang CX; Kong AN; Khor TO; Zheng X; Steele VE; Kopelovich L; Rao CV
    Cancer Res; 2006 Apr; 66(8):4542-6. PubMed ID: 16618783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice.
    Swamy MV; Patlolla JM; Steele VE; Kopelovich L; Reddy BS; Rao CV
    Cancer Res; 2006 Jul; 66(14):7370-7. PubMed ID: 16849589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids.
    Reddy BS; Patlolla JM; Simi B; Wang SH; Rao CV
    Cancer Res; 2005 Sep; 65(17):8022-7. PubMed ID: 16140976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
    Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
    Kawamori T; Rao CV; Seibert K; Reddy BS
    Cancer Res; 1998 Feb; 58(3):409-12. PubMed ID: 9458081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
    Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS
    Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet.
    Reddy BS; Nayini J; Tokumo K; Rigotty J; Zang E; Kelloff G
    Cancer Res; 1990 May; 50(9):2562-8. PubMed ID: 2109653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
    Samaha HS; Kelloff GJ; Steele V; Rao CV; Reddy BS
    Cancer Res; 1997 Apr; 57(7):1301-5. PubMed ID: 9102217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.
    Reddy BS; Rao CV; Seibert K
    Cancer Res; 1996 Oct; 56(20):4566-9. PubMed ID: 8840961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination.
    Rao CV; Tokumo K; Rigotty J; Zang E; Kelloff G; Reddy BS
    Cancer Res; 1991 Sep; 51(17):4528-34. PubMed ID: 1831401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats.
    Rao CV; Rivenson A; Katiwalla M; Kelloff GJ; Reddy BS
    Cancer Res; 1993 Jun; 53(11):2502-6. PubMed ID: 8495412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of experimental colon cancer by genistein.
    Rao CV; Wang CX; Simi B; Lubet R; Kelloff G; Steele V; Reddy BS
    Cancer Res; 1997 Sep; 57(17):3717-22. PubMed ID: 9288778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development.
    Reddy BS; Maruyama H; Kelloff G
    Cancer Res; 1987 Oct; 47(20):5340-6. PubMed ID: 3652039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of apoptosis in the modulation of colon carcinogenesis by dietary fat and by the organoselenium compound 1,4-phenylenebis(methylene)selenocyanate.
    Samaha HS; Hamid R; el-Bayoumy K; Rao CV; Reddy BS
    Cancer Epidemiol Biomarkers Prev; 1997 Sep; 6(9):699-704. PubMed ID: 9298577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane-induced colonic aberrant crypt foci formation in rats.
    Patlolla JM; Zhang Y; Li Q; Steele VE; Rao CV
    Int J Oncol; 2012 Jan; 40(1):170-5. PubMed ID: 21956158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.
    Kawamori T; Lubet R; Steele VE; Kelloff GJ; Kaskey RB; Rao CV; Reddy BS
    Cancer Res; 1999 Feb; 59(3):597-601. PubMed ID: 9973206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chemopreventive agents on intermediate biomarkers during different stages of azoxymethane-induced colon carcinogenesis.
    Singh J; Kelloff G; Reddy BS
    Cancer Epidemiol Biomarkers Prev; 1992; 1(5):405-11. PubMed ID: 1305473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
    Swamy MV; Cooma I; Reddy BS; Rao CV
    Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis.
    Abou-Issa HM; Alshafie GA; Seibert K; Koki AT; Masferrer JL; Harris RE
    Anticancer Res; 2001; 21(5):3425-32. PubMed ID: 11848504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.